Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Valneva SE

Start price
Target price
Perf. (%)
€24.38
25.11.21
€21.00
25.11.22
6.64%
26.11.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€5.37
24.11.21
€6.00
24.11.22
-24.21%
15.02.22

Could be worthwhile Investment >10% per year
buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.24
19.11.21
€2.60
19.11.22
-69.80%
20.11.22

Could be worthwhile Investment >10% per year
buy
AB Science S.A.

Start price
Target price
Perf. (%)
€12.40
19.11.21
€13.60
19.11.22
-34.44%
20.11.22

Could be worthwhile Investment >10% per year
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.24
17.11.21
€1.80
17.11.22
0.00%
19.11.21

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€21.24
15.11.21
€25.00
15.11.22
33.24%
27.11.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.30
12.11.21
€0.50
12.11.22
-78.55%
13.11.22

Could be worthwhile Investment >10% per year
buy
Nanobiotix

Start price
Target price
Perf. (%)
€8.51
11.11.21
€10.00
11.11.22
-53.17%
12.11.22

Could be worthwhile Investment >10% per year
buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.19
11.11.21
-
11.11.22
2.28%
17.11.21

Could be worthwhile Investment >10% per year
Virbac S.A.

Start price
Target price
Perf. (%)
€401.50
07.11.21
€385.00
07.11.22
-38.36%
22.10.22

Could be worthwhile Investment >10% per year
buy
Transgene S.A.

Start price
Target price
Perf. (%)
€2.43
07.11.21
€2.80
07.11.22
-20.58%
08.11.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€19.59
31.10.21
€30.00
31.10.22
8.63%
13.11.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Virbac S.A.

Start price
Target price
Perf. (%)
€395.50
25.10.21
€480.00
25.10.22
1.52%
07.11.21

Could be worthwhile Investment >10% per year
Advicenne

Start price
Target price
Perf. (%)
€7.24
17.10.21
€6.00
17.10.22
-43.92%
18.10.22

Could be worthwhile Investment >10% per year
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€5.86
07.10.21
€7.50
07.10.22
-8.28%
24.11.21

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€12.95
03.10.21
€20.00
03.10.22
15.83%
16.10.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.52
29.09.21
€0.75
29.09.22
-20.66%
09.10.21

Could be worthwhile Investment >10% per year
buy
Nicox S.A.

Start price
Target price
Perf. (%)
€3.19
29.09.21
€3.80
29.09.22
-46.37%
30.09.22

Could be worthwhile Investment >10% per year
buy
GenKyoTex S.A.

Start price
Target price
Perf. (%)
€3.18
28.09.21
€3.60
-
24.10.21

Could be worthwhile Investment >10% per year
Innate Pharma

Start price
Target price
Perf. (%)
€6.61
18.09.21
€3.00
18.09.22
-22.01%
02.10.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.82
14.09.21
-
14.09.22
-29.36%
15.09.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€11.82
14.09.21
€30.00
14.09.22
-29.36%
15.09.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
Standard Investments for future growth
Valneva SE

Start price
Target price
Perf. (%)
€11.84
13.09.21
-
13.09.22
139.19%
29.11.21

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
Valneva SE

Start price
Target price
Perf. (%)
€12.34
13.09.21
€9.00
13.09.22
100.65%
16.12.21

Could be very worthwhile Investment >20% year
Inventiva SA

Start price
Target price
Perf. (%)
€11.54
10.09.21
€8.00
10.09.22
-63.65%
11.09.22

Could be worthwhile Investment >10% per year